GoodRx Holdings, Inc. Business Acquisition, Pro Forma Revenue
GoodRx Holdings, Inc. (GDRX) reported Business Acquisition, Pro Forma Revenue of $767.13 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2025-02-27
- GoodRx Holdings, Inc. business acquisition, pro forma revenue for the quarter ending 2022-12-31 was $184.11M, a 13.77% decline year-over-year.
- GoodRx Holdings, Inc. business acquisition, pro forma revenue for the quarter ending 2022-09-30 was $187.32M, a 4.09% decline year-over-year.
- GoodRx Holdings, Inc. business acquisition, pro forma revenue for the quarter ending 2022-06-30 was $191.87M, a 8.48% increase year-over-year.
- GoodRx Holdings, Inc. business acquisition, pro forma revenue for the quarter ending 2022-03-31 was $203.82M.
- GoodRx Holdings, Inc. business acquisition, pro forma revenue for fiscal 2022 was $767.13M, a 2.79% increase from fiscal 2021.
- GoodRx Holdings, Inc. business acquisition, pro forma revenue for fiscal 2021 was $746.30M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2022-12-31 | $184.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $371.43M derived: sum of 2 quarters · filed 2025-02-27 | $563.30M derived: sum of 3 quarters · filed 2025-02-27 | $767.13M 10-K · filed 2025-02-27 |
| 2022-09-30 | $187.32M 10-Q · filed 2023-11-09 | $379.19M derived: sum of 2 quarters · filed 2023-11-09 | $583.02M 10-Q · filed 2023-11-09 | $796.53M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $191.87M 10-Q · filed 2023-08-09 | $395.70M 10-Q · filed 2023-08-09 | $609.21M derived: sum of 3 quarters · filed 2024-02-29 | $804.51M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $203.82M 10-Q · filed 2023-05-10 | $417.34M derived: sum of 2 quarters · filed 2024-02-29 | $612.64M derived: sum of 3 quarters · filed 2024-02-29 | $789.51M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $213.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $408.81M derived: sum of 2 quarters · filed 2024-02-29 | $585.68M derived: sum of 3 quarters · filed 2024-02-29 | $746.30M 10-K · filed 2024-02-29 |
| 2021-09-30 | $195.30M 10-Q · filed 2022-11-09 | $372.17M derived: sum of 2 quarters · filed 2022-11-09 | $532.78M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $176.87M 10-Q · filed 2022-08-09 | $337.49M 10-Q · filed 2022-08-09 |